Dec. 31, 2019 Price forecast | 2 weeks: 6.19% | 1 month: -5.30% | 3 months: -0.03%

LPCN stock forecast

Our latest prediction for Lipocine, Inc.'s stock price was made on the Dec. 31, 2019 when the stock price was at 0.38$.

In the short term (2weeks), LPCN's stock price should outperform the market by 6.19%. During that period the price should oscillate between -11.50% and +32.00%.

In the medium term (3months), LPCN's stock price should underperform the market by -0.03%. During that period the price should oscillate between -43.51% and +80.60%.

About Lipocine, Inc.

Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded in 2011 and is headquartered in Salt Lake City, UT.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.55$ per share.

The book value per share is 0.65$

Lipocine, Inc. website

Three months stock forecastDec. 31, 2019


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -13M - -13M -0.55 - - 24M 0.65 -11M - -11M